Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study

Title
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study
Authors
Keywords
Staphylococcus aureus, Vaccine, Functional antibodies, Capsular polysaccharide, Clumping factor A, Manganese transporter C
Journal
VACCINE
Volume 35, Issue 2, Pages 375-384
Publisher
Elsevier BV
Online
2016-12-01
DOI
10.1016/j.vaccine.2016.11.010

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started